Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 22. February 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9284  Previews Next
   
   Articles 1 - 20 / 185676  
   
Neoadjuvant Therapy in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer: Recent Progress, Challenges, and Future Directions in the Era of TAR-200 and Enfortumab Vedotin Plus Pembrolizumab.
Oncol Ther
Di Lorenzo G, Di Maio M, Buonerba C.
PMID: 41722015 [PubMed - as supplied by publisher]


Telesurgery in prostate cancer: a systematic review of clinical applications and future directions.
Prostate Cancer Prostatic Dis
Aksakal B, Soputro NA, Al-Bayati A, Secin M, Autorino R, Kaouk J, Olivares R.
PMID: 41721057 [PubMed - as supplied by publisher]


Mechanistic insights and clinical implications of RNA-binding proteins in prostate cancer.
Discov Oncol
Javankiani S, Khodarahmi M, Yarahmadi F, Mirzohreh ST, Soltani Moghadam S, Kavousinia P, Moradi S, Aghajamal Avval N, Baghdadi M, Sargazi Moghaddam N, Khanlari Goodarzi M, Zamen Milani N, Ahmadi Beni F, Behfar Q.
PMID: 41721034 [PubMed - as supplied by publisher]


ESR Essentials: MRI-based T-staging in prostate cancer-practice recommendations by the European Society of Urogenital Radiology.
Eur Radiol
Agrotis G, Jäderling F, Lakhani A, Moreira ASL, Kekelidze M, Rembak-Szynkiewicz J, Logager V, Thoeny H, Villeirs G, Woo S, Schoots IG.
PMID: 41720935 [PubMed - as supplied by publisher]


Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes.
Eur Urol Oncol
Longoni M, Scilipoti P, De Angelis M, Zaurito P, Tremolada G, Santangelo A, Simone G, Mastroianni R, Lonati C, Zamboni S, Suardi N, Marcq G, Szostek A, Velasco JC, Lafuente Puentedura A, Subiela JD, Del Olmo Durán P, , Karakiewicz PI, Pradere B, Soria F, Gontero P, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M, European Association of Urology.
PMID: 41720695 [PubMed - as supplied by publisher]


Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival.
Eur Urol Oncol
Kennedy OJ, Chauhan U, Gorman L, Lorigan P, Merriel SWD, Staa TV, Wright A, Ashcroft DM.
PMID: 41720694 [PubMed - as supplied by publisher]


Prognostic Nomograms and Scoring System: Novel Approaches to Forecast Overall Survival and Cancer-Specific Survival in Patients With Testicular Cancer.
Cancer Med
Huang X, Zhu L, Sun M, Zhou Y, Ding Y, Lin C.
PMID: 41720484 [PubMed - indexed for MEDLINE]


Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study.
Ann Oncol
Motzer RJ, Albiges L, Aguirre SAT, Kanesvaran R, Centkowski P, Reimers MA, Sade JP, Pouessel D, Biscaldi E, Esteban E, Arranz Arija JÁ, Tykodi SS, van Kooten Losio M, Dighe A, Ma H, Valmeekam V, Simmons A, Scheffold C, Andrianova S, Braun DA, Powles T, Choueiri TK.
PMID: 41720427 [PubMed - as supplied by publisher]


Listening to the bladder field: Urine liquid biopsies reveal differential treatment responses in NMIBC.
Cell
Jonas K, Moser T, Heitzer E.
PMID: 41720073 [PubMed - indexed for MEDLINE]


Machine learning based classification of aggressive and malignant renal tumors from multimodal data.
PLOS Digit Health
Aminy M, Gala T, Dasgupta A, Li S, Cen SY, Pawan SJ, Gill I, Duddalwar V, Oberai AA.
PMID: 41719307 [PubMed]


Evaluation, Optimization, and Validation of a Multiparametric CT Algorithm for Solid Renal Masses: CT-Score Version 2.0.
Radiol Imaging Cancer
Krishna S, Kandasamy M, Bhayana R, Nanda B, Diwan K, Kamona A, Sairafi S, Prendeville S, Deng Y, Finelli A, Davenport MS, Schieda N.
PMID: 41718533 [PubMed - indexed for MEDLINE]


Ciprofloxacin Versus Fosfomycin for Empirical Prophylaxis Before Transrectal Prostate Biopsy: Clinical, Microbiological, and Patient-Reported Outcomes from a Prospective Study.
Med Sci (Basel)
Burzinskis E, Janulaityte I, Burzinskiene G, Skaudickas D, Naudziunas A, Vitkauskiene A.
PMID: 41718138 [PubMed - indexed for MEDLINE]


Diagnostic Accuracy of PSMA-PET/CT vs. mpMRI in Primary Staging of Intermediate- and High-Risk Prostate Cancer.
Med Sci (Basel)
Talavera Cobo V, Yánez Ruiz CA, Tapia Tapia MD, Calva Lopez A, Muñoz Bastidas CA, Ancizu Marckert FJ, Torres Roca M, Huerta LL, Sanchez Zalabardo D, Diez-Caballero Alonso FJ, Guillen-Grima F, Robles García JE, Miñana-López B.
PMID: 41718112 [PubMed - indexed for MEDLINE]


Erectile Dysfunction and Its Impact on Health-Related Quality of Life in Prostate Cancer Patients: A Multicenter Cross-Sectional Study from Pakistan.
Epidemiologia (Basel)
Abbas M, Gajdács M, Balogh G, Ahmed S, Mahfooz R, Khan A.
PMID: 41718049 [PubMed]


Network pharmacology research integrating LC-MS/MS, machine learning, molecular docking, and dynamics simulation: key biomarkers and potential mechanisms of Phellinus igniarius against prostate cancer.
In Silico Pharmacol
Ren Z, Liu X, Zhang J, Song M, Yang Q, Li C, Liu D.
PMID: 41717432 [PubMed]


Positive predictive value of the prostate imaging reporting and data system combined with single related indicators in prostate cancer across different prostate zones.
Front Oncol
Shen X, Yang L, Wang S, Shen J.
PMID: 41717420 [PubMed]


Advancing CAR-T therapy in prostate cancer: overcoming the tumor microenvironment and enhancing efficacy.
Front Oncol
Zhou Z, Lao Y, Zhao K, Cheng L, Xiao X, Li W, Liu S, Kong X, Dong Z.
PMID: 41717407 [PubMed]


Tislelizumab Combined With Axitinib in Neoadjuvant Treatment of Locally Advanced Clear Cell Renal Cell Carcinoma: A Single-Center, Phase II Clinical Study.
MedComm (2020)
Yang W, Zhang S, Liu G, Li H, Wang X, Jiang B, Zhang G, Guo H, Ji C.
PMID: 41716961 [PubMed]


Blood inflammatory markers combined with tumor markers for differentiating benign prostatic hyperplasia from prostate cancer.
Front Med (Lausanne)
Liu Z, Yang X, Hou X, Du P, Jia K.
PMID: 41716796 [PubMed]


Re: Rui M. Bernardino, Leyi B. Yin, Katherine Lajkosz, et al. Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective Trial. Eur Urol Open Sci 2025;82:52-8.
Eur Urol Open Sci
Wu W, Li N, Zhang H.
PMID: 41716568 [PubMed]


   
   Articles 1 - 20 / 185676    Page 1 of 9284  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1